PPARGC1A and endometrial carcinoma: Focusing on the PPARγ Coactivator 1 alpha (PGC-1α), Cormio et al. employed 52 patient-derived endometrial tissue samples and highlighted the direct association of the enhanced mitochondrial biogenesis in type I endometrial carcinoma with the increased PGC-1α signaling pathway [36].